ReachMD
Be part of the knowledge.™Project Oncology®
Multidisciplinary Approaches & Considerations on Collaborative Care for Patients with HER2m NSCLC
Multidisciplinary Approaches & Considerations on Collaborative Care for Patients with HER2m NSCLC
Project Oncology®
Exploring Therapeutic Updates for Lymphoma
Exploring Therapeutic Updates for Lymphoma
Project Oncology®
Addressing CLL Fatigue & Improving the Patient Experience
Addressing CLL Fatigue & Improving the Patient Experience
Project Oncology®
Exploring Treatment Approaches in CLL Management
Exploring Treatment Approaches in CLL Management
- 0
Project Oncology®
Hot Topics on NSCLC from 2021 ESMO
Hot Topics on NSCLC from 2021 ESMO
- 0
Project Oncology®
Understanding the Biology to Target K-RAS Driven Tumors: Notes from a Presentation at ESMO 2021
Understanding the Biology to Target K-RAS Driven Tumors: Notes from a Presentation at ESMO 2021
- 0
CME/CE
Optimizing Treatment Selection and Side Effect Management in BRAF-Mutant Melanoma
Optimizing Treatment Selection and Side Effect Management in BRAF-Mutant Melanoma
CME/CE
Evolving Management Strategies for BRAF-Mutant Metastatic Colorectal Cancer
Evolving Management Strategies for BRAF-Mutant Metastatic Colorectal Cancer
CME/CE
Keeping Pace in GU Cancers: Clinical Considerations for Prostate Cancer – Global Perspectives
Keeping Pace in GU Cancers: Clinical Considerations for Prostate Cancer – Global Perspectives
- 0
CME/CE
Optimizing Community-Based Decisions: HER2-Positive Metastatic Breast Cancer
Optimizing Community-Based Decisions: HER2-Positive Metastatic Breast Cancer
CME/CE
RCC Treatment Strategies in a Favorable-Risk Patient
RCC Treatment Strategies in a Favorable-Risk Patient
CME/CE
State of the Union: Advances in the Management of mUC
State of the Union: Advances in the Management of mUC
- 0
Live Broadcast
Understanding Unresectable Stage III NSCLC: A Radiation Oncologist’s Perspective
Understanding Unresectable Stage III NSCLC: A Radiation Oncologist’s Perspective
December 08, 2021
06:00 PM - 06:20 PM EST
- 0
Live Broadcast
Understanding Unresectable Stage III NSCLC: A Radiation Oncologist’s Perspective
Understanding Unresectable Stage III NSCLC: A Radiation Oncologist’s Perspective
December 08, 2021
09:00 PM - 09:20 PM EST
- 0
Medical Industry Feature
HCC Surveillance: Evaluating Evolving Data & Impacts on Outcomes
HCC Surveillance: Evaluating Evolving Data & Impacts on Outcomes
Medical Industry Feature
Integrating Real-World Evidence into Oncology Practice: A Closer Look at Biosimilars
Integrating Real-World Evidence into Oncology Practice: A Closer Look at Biosimilars
Medical Industry Feature
Exploring Emerging Advancements in Early Cancer Detection
Exploring Emerging Advancements in Early Cancer Detection
- 0
Medical Industry Feature
Review Regimens for the Treatment of Relapsed/Refractory Multiple Myeloma
Review Regimens for the Treatment of Relapsed/Refractory Multiple Myeloma
prnewswire.com:443
11/19/2021- prnewswire.com
11/19/2021
- prnewswire.com:443
11/11/2021
- newatlas.com
11/12/2021
- newsbreak.com
11/12/2021
- medicalxpress.com
11/08/2021